JP2012531448A5 - - Google Patents

Download PDF

Info

Publication number
JP2012531448A5
JP2012531448A5 JP2012518003A JP2012518003A JP2012531448A5 JP 2012531448 A5 JP2012531448 A5 JP 2012531448A5 JP 2012518003 A JP2012518003 A JP 2012518003A JP 2012518003 A JP2012518003 A JP 2012518003A JP 2012531448 A5 JP2012531448 A5 JP 2012531448A5
Authority
JP
Japan
Prior art keywords
berberine
pharmaceutical composition
biologically equivalent
topical pharmaceutical
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012518003A
Other languages
English (en)
Japanese (ja)
Other versions
JP6159084B2 (ja
JP2012531448A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/CN2010/000983 external-priority patent/WO2011000218A1/en
Publication of JP2012531448A publication Critical patent/JP2012531448A/ja
Publication of JP2012531448A5 publication Critical patent/JP2012531448A5/ja
Application granted granted Critical
Publication of JP6159084B2 publication Critical patent/JP6159084B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012518003A 2009-06-30 2010-06-30 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物 Expired - Fee Related JP6159084B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22172509P 2009-06-30 2009-06-30
US61/221,725 2009-06-30
PCT/CN2010/000983 WO2011000218A1 (en) 2009-06-30 2010-06-30 Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2017029388A Division JP2017082019A (ja) 2009-06-30 2017-02-20 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物

Publications (3)

Publication Number Publication Date
JP2012531448A JP2012531448A (ja) 2012-12-10
JP2012531448A5 true JP2012531448A5 (enExample) 2013-08-01
JP6159084B2 JP6159084B2 (ja) 2017-07-05

Family

ID=43410481

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2012518003A Expired - Fee Related JP6159084B2 (ja) 2009-06-30 2010-06-30 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物
JP2017029388A Withdrawn JP2017082019A (ja) 2009-06-30 2017-02-20 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2017029388A Withdrawn JP2017082019A (ja) 2009-06-30 2017-02-20 酒さまたは赤面に関連する皮膚疾患を治療するための、ベルベリンまたはその類似体を含有する組成物

Country Status (16)

Country Link
US (1) US9486402B2 (enExample)
EP (1) EP2448577B1 (enExample)
JP (2) JP6159084B2 (enExample)
KR (3) KR20170116231A (enExample)
CN (2) CN102481290A (enExample)
AU (1) AU2010268647B2 (enExample)
BR (1) BRPI1012128A2 (enExample)
CA (1) CA2766834C (enExample)
ES (1) ES2600909T3 (enExample)
HK (1) HK1224206A1 (enExample)
IL (1) IL217264A (enExample)
MX (1) MX344787B (enExample)
NZ (1) NZ597645A (enExample)
PL (1) PL2448577T3 (enExample)
RU (2) RU2533458C2 (enExample)
WO (1) WO2011000218A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160263092A1 (en) 2013-12-19 2016-09-15 Twi Biotechnology, Inc. Therapeutic uses of berberine formulations
TW201538156A (zh) * 2013-12-19 2015-10-16 Twi Biotechnology Inc 小蘗鹼配方及其用途
AU2016282800A1 (en) * 2015-06-24 2018-02-01 Twi Biotechnology, Inc. Therapeutic uses of berberine formulations
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
EP3445330B1 (en) 2016-04-19 2022-07-06 The U.S.A. as represented by the Secretary, Department of Health and Human Services Use of gram negative species to treat atopic dermatitis
EP3570835B1 (en) * 2017-01-19 2023-08-09 TWI Biotechnology, Inc. Diacerein for preventing or treating immunoinflammatory dermal disorders
EP3398448A1 (en) 2017-05-05 2018-11-07 Vall Garraf, S.L. Fattening additive for animal nutritional composition
CN111601617A (zh) 2017-12-13 2020-08-28 上海岸阔医药科技有限公司 一种用于预防或治疗与egfr 被抑制相关疾病的方法
JP7520366B2 (ja) 2018-04-16 2024-07-23 オンクオリティー ファーマシューティカルズ チャイナ リミテッド 腫瘍療法の副作用の予防または治療方法
EP3784260A4 (en) * 2018-04-18 2022-03-09 Forte Subsidiary, Inc. Compositions for the treatment of skin conditions
CN108329310A (zh) * 2018-05-07 2018-07-27 深圳市迪克曼科技开发有限公司 黄藤素的制备方法
KR20210013080A (ko) 2018-05-11 2021-02-03 포르테 서브시디어리, 인크. 피부 병태의 치료를 위한 조성물
CN110882246B (zh) * 2018-09-08 2022-12-23 西南大学 不同生物活性的黄连生物碱的提取方法及应用
JP2020045338A (ja) * 2018-09-12 2020-03-26 大正製薬株式会社 外用組成物
IL281761B2 (en) 2018-09-25 2025-09-01 Ponce De Leon Health Designated Activity Company Process for preparing calcium alpha-ketoglutarate
JP6535146B1 (ja) * 2019-03-08 2019-06-26 佐藤製薬株式会社 皮膚バリア機能改善剤
RU2697854C1 (ru) * 2019-05-14 2019-08-21 Федеральное государственное бюджетное образовательное учреждение высшего образования "Сибирский государственный медицинский университет" Министерства здравоохранения Российской Федерации Способ комбинированной наружной терапии эритематозно-папулезной розацеа
CN113440613A (zh) * 2020-03-26 2021-09-28 轶诺(浙江)药业有限公司 小檗碱类似物与jak抑制剂在胃肠道炎症性疾病治疗中的用途
CN116370469A (zh) * 2023-04-27 2023-07-04 常州大学 四氢小檗碱类化合物对trpv3的抑制应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6150920A (ja) * 1984-08-20 1986-03-13 Ichimaru Fuarukosu Kk 黄柏抽出エキス含有液の製造法
JPS63179812A (ja) * 1987-01-22 1988-07-23 Shiseido Co Ltd 皮膚外用剤
JP2609564B2 (ja) * 1991-05-31 1997-05-14 政夫 斎藤 アレルギー性皮膚炎用クリーム及びその製造方法
CN1085600A (zh) * 1993-07-07 1994-04-20 南宁市迪生新技术研究所 防治性病、传染病的杀菌保健香皂和浴液
CN1182788A (zh) * 1997-02-03 1998-05-27 熊光明 一种防治性病传染病的保健洗涤用品
US6482839B1 (en) 1997-06-02 2002-11-19 Cellegy Pharmaceuticals, Inc. Pyridine-thiols for treatment of a follicular dermatosis
US6440465B1 (en) * 2000-05-01 2002-08-27 Bioderm, Inc. Topical composition for the treatment of psoriasis and related skin disorders
JP2001335485A (ja) * 2000-05-31 2001-12-04 Pola Chem Ind Inc メラノサイトのデンドライトの伸長抑制剤及びそれを含有する化粧料
KR20030082200A (ko) * 2002-04-17 2003-10-22 주식회사 엘지생활건강 베르베린을 함유하는 아토피성 피부염 예방 및 완화용조성물
US20040146539A1 (en) 2003-01-24 2004-07-29 Gupta Shyam K. Topical Nutraceutical Compositions with Selective Body Slimming and Tone Firming Antiaging Benefits
WO2004093876A2 (en) * 2003-04-03 2004-11-04 The Board Of Trustees Of The University Of Illinois Composition containing berberine or a derivative thereof and an antimicrobial agent or an antibiotic agent, and their use for treating oral pathogens and other disorders
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
KR101045658B1 (ko) 2003-11-17 2011-07-01 쎄데르마 테트라펩티드 및 트리펩티드 혼합물을 포함하는 조성물
US20050158404A1 (en) 2003-11-18 2005-07-21 Goodless Dean R. Composition and method for treatment of acne
EP1591125A1 (de) * 2004-04-19 2005-11-02 Universitätsklinikum Freiburg Pharmazeutische Zusammensetzung enthaltend Extrakte aus Flechten und Johanniskraut
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
CN100441183C (zh) * 2005-08-29 2008-12-10 中国医学科学院皮肤病研究所 盐酸13-己基小檗碱和盐酸13-己基巴马汀制备治疗湿疹、皮炎和银屑病的药物用途
DE202010004750U1 (de) * 2010-04-09 2011-10-11 Biofrontera Bioscience Gmbh Pharmazeutische oder/und kosmetische Zusammensetzung zur Behandlung der Haut

Similar Documents

Publication Publication Date Title
JP2012531448A5 (enExample)
AU2014252157B2 (en) Composition and formulation of antimicrobial agents, processes thereof and methods for treating microbial infections
NZ597645A (en) Compositions containing berberine or analogs thereof for treating rosacea or red face related skin disorders
RU2013141845A (ru) Фармацевтическая композиция в виде крема, содержащая оксиметазолин, для лечения симптомов розацеа
JP2011529038A5 (enExample)
JP5740393B2 (ja) 皮膚および爪の真菌感染症の局所治療に適した組成物
RU2013125021A (ru) Местные композиции для сохранения или восстановления целостности слизистых оболочек
JP2008543854A (ja) 炎症状態を治療するための組成物および方法
WO2007102243A1 (ja) 外用の医薬組成物
PT1560589E (pt) Novos complexos de ésteres de ácidos gordos de polihidroxialcanos e niacinamida
BRPI0508933A (pt) composições para entrega tópica
JP6842794B2 (ja) 皮膚外用製剤
KR20170036058A (ko) 코 적용을 위한 시네올-함유 조성물
RU2012149863A (ru) Полисахарид семени тамаринда для применения в лечении микробных инфекций
AR065317A1 (es) Uso de quitosanos, derivados de quitosanos y una sal fisiologicamente aceptable del mismo para el tratamiento de enfermedades inflamatorias ungueales
JP2016147914A (ja) 上気道の疾患およびインフルエンザ症候群を治療するための組成物
RU2012149868A (ru) Полисахарид семян для применения в лечении воспалительных заболеваний
EP1670464B1 (en) Topical compositions comprising telmesteine for treating dermatological disorders
HK1198632A1 (en) Compositions comprising cimetidine and n,o-carboxymethyl chitosan for the prevention and therapy of pathologies of the skin and the mucous membranes and in the odontostomatological field
RU2018125252A (ru) Синергическая комбинация пирролидонкарбоновой кислоты и/или ее солей и гиалуроновой кислоты и/или ее солей для применения в лечении и/или профилактике сухости и раздражения слизистых оболочек, и связанные фармацевтические композиции
JP2020525452A5 (enExample)
JP6253495B2 (ja) ロキソプロフェンを含有する外用剤組成物
JP2012530709A5 (enExample)
JP6679299B2 (ja) ニキビ治療用外用医薬組成物
JP7592526B2 (ja) Trpv1活性抑制剤、およびその利用